HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sunscreen Innovation Act Starts Clock Ticking On FDA Review Of TEAs

This article was originally published in The Rose Sheet

Executive Summary

Congress passes legislation to streamline FDA’s process for reviewing UV filter TEA submissions. The bill’s passing during Congress’ lame duck session reflects not only bipartisan support, but also lobbying by the personal-care product industry and consumer-health advocates to impose deadlines on FDA for long-sought changes to the OTC drug sunscreen monograph.

You may also be interested in...



'Data Gaps' Keep 12 Ingredients Off FDA's Proposed OTC Sunscreen Monograph

FDA proposed final sunscreen monograph identifies zinc oxide and titanium dioxide as GRASE, two other ingredients as non-GRASE and 12 substances with data gaps, meaning firms must provide safety and effectiveness data or reformulate products that rely on inadequately supported UV filters. EWG says the proposal is “exactly the kind of signal that FDA should be providing for the sunscreen industry.”

EU Eyeing Carcinogen Tag For Titanium Dioxide Under CLP Reg; Why It Matters For Cosmetics

TiO2's nano-form use in spray sunscreens is already prohibited in the EU under the Cosmetics Regulation, but broader restrictions potentially extending to other cosmetic categories could be imposed down the line following a proposal from ECHA's Committee for Risk Assessment that the ingredient be CLP-classified as a suspected carcinogen when inhaled. There are also potential ramifications stateside to consider.

Could Gottlieb Bring Red-Tape Scissors To FDA Sunscreen Review?

FDA Commissioner nominee Scott Gottlieb has been a vocal critic of FDA bureaucracy and excessive data demands that in his view have slowed access to life-saving drugs and medical devices in the US. His expected confirmation as FDA head could offer a new glimmer of hope to sponsors seeking GRASE status for next-generation UV filters, a process that has all but ground to a halt, according to industry advocates.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel